Handelsbanken Fonder AB - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$645
-13.0%
30,9330.0%0.00%0.0%
Q2 2023$741
+54.7%
30,933
+21.6%
0.00%
+33.3%
Q1 2023$479
+18.3%
25,4330.0%0.00%0.0%
Q4 2022$405
-99.9%
25,433
+3.2%
0.00%0.0%
Q3 2022$403,000
+16.1%
24,6330.0%0.00%
+50.0%
Q2 2022$347,000
-31.6%
24,633
+17.7%
0.00%
-33.3%
Q1 2022$507,000
+14.2%
20,933
+10.0%
0.00%
+50.0%
Q4 2021$444,000
-18.4%
19,033
-41.9%
0.00%
-33.3%
Q3 2021$544,000
-31.8%
32,7330.0%0.00%
-25.0%
Q2 2021$798,000
+32.6%
32,733
+40.3%
0.00%
+33.3%
Q1 2021$602,000
-51.7%
23,3330.0%0.00%
-62.5%
Q4 2020$1,247,000
+29.6%
23,3330.0%0.01%
+14.3%
Q3 2020$962,000
-57.5%
23,333
-50.0%
0.01%
-30.0%
Q2 2020$2,262,000
-84.5%
46,666
-92.8%
0.01%
-93.4%
Q1 2018$14,606,000
+15.5%
650,000
+54.8%
0.15%
+1.3%
Q4 2017$12,646,000
-11.7%
420,000
+10.5%
0.15%
-16.7%
Q3 2017$14,314,000
+189.9%
380,000
+114.7%
0.18%
+42.9%
Q2 2017$4,937,000
-8.5%
177,000
+12.7%
0.13%
-16.0%
Q1 2017$5,398,000
+56.0%
157,000
+30.8%
0.15%
+41.5%
Q4 2016$3,461,000
+204.7%
120,000
+242.9%
0.11%
+125.5%
Q2 2016$1,136,000
-3.2%
35,000
-16.7%
0.05%
-6.0%
Q1 2016$1,174,000
-72.7%
42,000
-65.1%
0.05%
-39.8%
Q4 2015$4,296,000120,5000.08%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Baker Brothers Advisors 28,439,114$590,396,0003.89%
GREAT POINT PARTNERS LLC 1,196,098$24,831,0003.87%
EMORY UNIVERSITY 196,601$4,081,0002.67%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
NEXTHERA CAPITAL LP 500,000$10,380,0001.99%
Palo Alto Investors LP 1,684,180$34,964,0001.41%
Opus Point Partners Management, LLC 20,828$432,0001.03%
Opaleye Management Inc. 195,000$4,048,0001.03%
GARRISON BRADFORD & ASSOCIATES INC 48,500$1,007,0000.81%
View complete list of ACADIA PHARMACEUTICALS INC shareholders